Pharma brands are losing their shine with US consumers who are now thinking about the economy and inflation instead of Covid. (Credit: Shutterstock)

Phar­ma brands fade in an­nu­al Har­ris con­sumer vis­i­bil­i­ty poll: Mod­er­na drops off and Pfiz­er dips

As Covid-19 con­cerns are fad­ing in the US, so is bio­phar­ma vis­i­bil­i­ty. The an­nu­al Ax­ios Har­ris Poll sur­vey to de­ter­mine and rank the 100 most top-of-mind brands in the US finds Mod­er­na, which was No. 3 last year, not on the list at all for 2022, and Pfiz­er sink­ing 37 spots.

How­ev­er, it’s not that Mod­er­na or Pfiz­er did any­thing wrong, it’s just that Amer­i­cans have moved on to oth­er wor­ries be­yond Covid.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.